Colby Kash

CEO

Dr. Colby Kash is the Chief Executive Officer and co-founder of Camelot BioCapital, a biotechnology venture studio and advisory firm focused on advancing innovative technologies that increase the human healthspan. Dr. Kash directs a team of physicians, scientists, and investment experts, in inventing, developing, and financing groundbreaking healthcare solutions. Camelot’s portfolios have collectively syndicated over $100 million for the research and development of novel therapeutics targeting cancer, autoimmune and anti-aging disease areas.
Dr. Kash was appointed as the inaugural Executive in Residence at the University of Florida’s college of Health and Human performance, where he teaches and mentors the next generation of innovators in venture creation. He also serves as a member to the Industry Applied Physiology Advisory Board.
Dr. Kash is also the author of, The Autoimmune Plague: How to Regain Sovereignty Over Your Body and Life. Trained as a wellness and longevity functional medicine practitioner, he is a sought-after keynote speaker on healthcare topics and has been featured in prominent organizations such as the, the University of Florida, University of Miami, Young Presidents’ Organization, Authority Magazine, Thrive Global, The Epoch Times, and Health Professional Radio. In 2024, Dr. Kash was recognized as a 40 Under 40 Honoree by the University of Florida Alumni Association.
He holds a Doctor of Chiropractic and a Master of Science in Applied Clinical Nutrition from the Northeast College of Health Sciences, and a Bachelor of Science in Applied Physiology and Kinesiology from the University of Florida. Dr. Kash’s expertise is further supported by past advanced certifications, including ADAPT Functional Medicine and American College of Sports Medicine Certified Exercise Physiologist.